GlucoTrack (GCTK) said Tuesday it has priced a "best efforts" public offering of about 2.6 million shares at $1.15 a share to raise some $3.0 million.
The offering, with Dawson James Securities as the placement agent, is expected to close Wednesday, the medical technology company said.
The shares were down over 7% in recent trading.
Price: 1.06, Change: -0.09, Percent Change: -7.46
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.